Cargando…
GR3027 reversal of neurosteroid-induced, GABA-A receptor-mediated inhibition of human brain function: an allopregnanolone challenge study
RATIONALE: GR3027 is a novel small molecule GABA-A receptor-modulating steroid antagonist, which in non-clinical studies has shown promise for treatment of human disorders due to allosteric over-activation of GABA-A receptors by neurosteroids, such as allopregnanolone. We here studied its safety, ph...
Autores principales: | Johansson, Maja, Månsson, Maria, Lins, Lars-Eric, Scharschmidt, Bruce, Doverskog, Magnus, Bäckström, Torbjörn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919995/ https://www.ncbi.nlm.nih.gov/pubmed/29492615 http://dx.doi.org/10.1007/s00213-018-4864-1 |
Ejemplares similares
-
Extra-Synaptic GABA(A) Receptor Potentiation and Neurosteroid-Induced Learning Deficits Are Inhibited by GR3027, a GABA(A) Modulating Steroid Antagonist
por: Bengtsson, Sara K. S., et al.
Publicado: (2023) -
GR3027 antagonizes GABA(A) receptor-potentiating neurosteroids and restores spatial learning and motor coordination in rats with chronic hyperammonemia and hepatic encephalopathy
por: Johansson, Maja, et al.
Publicado: (2015) -
Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?
por: Wetten, Aaron, et al.
Publicado: (2022) -
Allopregnanolone preferentially induces energy‐rich food intake in male Wistar rats
por: Holmberg, Ellinor, et al.
Publicado: (2014) -
Allopregnanolone: A neurosteroid for managing acute and chronic pain conditions
por: Nair, Abhijit S., et al.
Publicado: (2019)